Ideaship, a venture capital firm by Global Technology Transfer Group, has invested in mpathic, an innovative company at the forefront of integrating conversation analytics with artificial intelligence.
mpathic’s mission is to elevate precision in life sciences and healthcare by applying advanced AI to enhance human understanding and communication, ultimately leading to improved clinical outcomes.
Their approach is grounded in the science of human communication and behaviors, drawing on decades of clinical research. “This expertise allows mpathic to optimize patient and clinical trial outcomes, creating a new standard of care”, remarked Michael Lubitz, Managing Director and Founder of Ideaship and Global Technology Transfer Group.
We’re excited to support mpathic in their innovative approach to deploying AI-driven insights to improve clinical and therapeutic outcomes.
To learn more about mpathic, visit their website: https://mpathic.ai/